NASDAQ:PAVMZ PAVmed (PAVMZ) Stock Price, News & Analysis → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free PAVMZ Stock Alerts $0.06 -0.01 (-14.29%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$0.03▼$0.0750-Day Range$0.02▼$0.0752-Week Range$0.00▼$0.27Volume29,743 shsAverage Volume11,795 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial Media Get PAVmed alerts: Email Address Ad Awesomely, LLCAutomatic Income (from home)Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…Watch this short video About PAVmed Stock (NASDAQ:PAVMZ)PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.Read More PAVMZ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PAVMZ Stock News HeadlinesMay 14, 2024 | investorplace.comPAVM Stock Earnings: PAVmed Beats EPS, Misses Revenue for Q1 2024March 27, 2024 | investorplace.comPAVM Stock Earnings: PAVmed Beats EPS, Misses Revenue for Q4 2023See More Headlines Receive PAVMZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PAVmed and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolNASDAQ:PAVMZ CUSIPN/A CIK1624326 Webwww.pavm.com Phone12129494319FaxN/AEmployees107Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$3.02 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesDr. Lishan Aklog M.D. (Age 58)Chairman & CEO Comp: $945.09kMr. Dennis M. McGrath CPA (Age 67)President, CFO & Corporate Secretary Comp: $663.38kMr. Shaun M. O'Neill M.B.A. (Age 41)Executive VP & COO Comp: $447.47kDr. Brian J. deGuzman M.D. (Age 59)Executive VP, Chief Technology & Compliance Officer Comp: $427.6kDr. Suman M. Verma M.D.Ph.D., Senior VP of Molecular Genetics & Chief Scientific OfficerMichael ParksVice President of Investor RelationsMr. Michael Adam Gordon (Age 50)Executive VP, General Counsel & Secretary Dr. Deepika A. Lakhani Ph.D.Senior VP, Chief Regulatory & Quality OfficerDr. Victoria T. Lee M.D.Senior VP & Chief Medical OfficerMore ExecutivesKey CompetitorsAinosNASDAQ:AIMDWBone BiologicsNASDAQ:BBLGWDIH Holding USNASDAQ:DHAIWEnvoy MedicalNASDAQ:COCHWHeart Test LaboratoriesNASDAQ:HSCSWView All Competitors PAVMZ Stock Analysis - Frequently Asked Questions How have PAVMZ shares performed in 2024? PAVmed's stock was trading at $0.11 at the beginning of 2024. Since then, PAVMZ stock has decreased by 45.5% and is now trading at $0.06. View the best growth stocks for 2024 here. How do I buy shares of PAVmed? Shares of PAVMZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PAVMZ) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.